Nucrogene

Nucrogene Pharmaceuticals Inc, is engaging in development, manufacture, commercialization and market innovative specialty generic prescription medicines as well as a over the counter medicines. Nucrogene generic pharmaceutical develop products with focus on wide range of therapeutic areas including, cardiovascular, proton pump inhibitors, anti-infective and anti-inflammatory diseases and other medical situation in the United States, Latin America, Europe and international market. Dosage forms include immediate release (IR), modified release (MR) and extended release(ER) of tablets, capsules and injectable. Nucrogene’s goal is to come up with innovations in generic medicines, improved quality of life for patients from high quality, cost effective medicines.